Pro Feature
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moDOXYCYCLINE HYCLATE (doxycycline hyclate) by Pfizer is clinical pharmacology tetracyclines are readily absorbed and are bound to plasma proteins in varying degree. Approved for infections caused by the following gram-negative microorganisms, infections caused by the following gram-positive microorganisms, 74 percent of enterococcus faecalis have been found to be resistant to tetracycline drugs and 11 more indications. First approved in 2024.
Drug data last refreshed 23h ago
CLINICAL PHARMACOLOGY Tetracyclines are readily absorbed and are bound to plasma proteins in varying degree. They are concentrated by the liver in the bile, and excreted in the urine and feces at high concentrations and in a biologically active form. Following a single 100 mg dose administered in a…
Worked on DOXYCYCLINE HYCLATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Tetracycline-class Drug
Double-blind-randomized,Placebo Controlled Trial for Chemotherapy-associated Oral Mucositis Using Doxycycline Hyclate
Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo